These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 5569980
1. Effect of age and sex on human drug metabolism. O'Malley K, Crooks J, Duke E, Stevenson IH. Br Med J; 1971 Sep 11; 3(5775):607-9. PubMed ID: 5569980 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of drugs in rabbits with experimental acute renal failure. Van Peer A, Belpaire F, Bogaert M. Pharmacology; 1978 Sep 11; 17(6):307-14. PubMed ID: 733890 [Abstract] [Full Text] [Related]
5. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia. Anderson KE, Peterson CM, Alvares AP, Kappas A. Clin Pharmacol Ther; 1977 Nov 11; 22(5 Pt 1):580-7. PubMed ID: 913026 [No Abstract] [Full Text] [Related]
6. Effect of oral contraceptives on plasma clearance. Carter DE, Bressler R, Hughes MR, Haussler MR, Christian D, Heine MW. Clin Pharmacol Ther; 1975 Dec 11; 18(6):700-7. PubMed ID: 173489 [Abstract] [Full Text] [Related]
9. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Bach B, Hansen JM, Kampmann JP, Rasmussen SN, Skovsted L. Clin Pharmacokinet; 1981 Dec 11; 6(5):389-96. PubMed ID: 7333060 [Abstract] [Full Text] [Related]
10. Drug metabolism in a geriatric population. O'Malley K, Stevenson IH, Crooks J. Clin Sci; 1971 Aug 11; 41(2):6P. PubMed ID: 5564320 [No Abstract] [Full Text] [Related]
11. Effect of age on antipyrine metabolism in patients with gastric cancer. Higuchi T, Nakamura T, Uchino H. J Natl Cancer Inst; 1980 Nov 11; 65(5):897-900. PubMed ID: 6933259 [Abstract] [Full Text] [Related]
12. Elimination of antipyrine from saliva as a measure of metabolism in man. Welch RM, DeAngelis RL, Wingfield M, Farmer TW. Clin Pharmacol Ther; 1975 Sep 11; 18(3):249-58. PubMed ID: 1164815 [Abstract] [Full Text] [Related]
13. Enflurane anesthesia and antipyrine metabolism. Duvaldestin P, Mauge F, Desmonts JM. Clin Pharmacol Ther; 1981 Jan 11; 29(1):61-4. PubMed ID: 7460476 [Abstract] [Full Text] [Related]
15. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R. Clin Pharmacol Ther; 1975 Oct 11; 18(4):425-32. PubMed ID: 1164824 [Abstract] [Full Text] [Related]
16. Individual differences in the plasma half-lives of lipid soluble drugs in man. Davies DS, Thorgeirsson SS. Acta Pharmacol Toxicol (Copenh); 1971 Oct 11; 29 Suppl 3():181-90. PubMed ID: 5316400 [No Abstract] [Full Text] [Related]
17. Antipyrine disposition and liver size in the elderly. Swift CG, Homeida M, Halliwell M, Roberts CJ. Eur J Clin Pharmacol; 1978 Nov 16; 14(2):149-52. PubMed ID: 720377 [Abstract] [Full Text] [Related]
18. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. Vesell ES, Page JG. J Clin Invest; 1969 Dec 16; 48(12):2202-9. PubMed ID: 5389794 [Abstract] [Full Text] [Related]
19. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo. Rowland M. Eur J Pharmacol; 1972 Mar 16; 17(3):352-6. PubMed ID: 5022150 [No Abstract] [Full Text] [Related]